Effect of Treatment of Obstructive Sleep Apnea on Depressive Symptoms: Systematic Review and Meta-Analysis

English version České info

Background:
Obstructive sleep apnea (OSA) is associated with increased morbidity and mortality, and decreased quality of life. Treatment with continuous positive airway pressure (CPAP) or mandibular advancement devices (MADs) is effective for many symptoms of OSA. However, it remains controversial whether treatment with CPAP or MAD also improves depressive symptoms.

Methods and Findings:
We performed a systematic review and meta-analysis of randomized controlled trials that examined the effect of CPAP or MADs on depressive symptoms in patients with OSA. We searched Medline, EMBASE, the Cochrane Central Registry of Controlled Trials, and PsycINFO from the inception of the databases until August 15, 2014, for relevant articles.

In a random effects meta-analysis of 19 identified trials, CPAP treatment resulted in an improvement in depressive symptoms compared to control, but with significant heterogeneity between trials (Q statistic, p<0.001; I² = 71.3%, 95% CI: 54%, 82%). CPAP treatment resulted in significantly greater improvement in depressive symptoms in the two trials with a higher burden of depression at baseline (meta-regression, p<0.001). The pooled standardized mean difference (SMD) in depressive symptoms with CPAP treatment in these two trial populations with baseline depression was 2.004 (95% CI: 1.387, 2.621), compared to 0.197 (95% CI: 0.059, 0.334) for 15 trials of populations without depression at baseline. Pooled estimates of the treatment effect of CPAP were greater in parallel arm trials than in crossover trials (meta-regression, p = 0.076). Random effects meta-analysis of five trials of MADs showed a significant improvement in depressive symptoms with MADs versus controls: SMD = 0.214 (95% CI: 0.026, 0.401) without significant heterogeneity (I² = 0%, 95% CI: 0%, 79%). Studies were limited by the use of depressive symptom scales that have not been validated specifically in people with OSA.

Conclusions:
CPAP and MADs may be useful components of treatment of depressive symptoms in individuals with OSA and depression. The efficacy of CPAP and MADs compared to standard therapies for depression is unknown.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Effect of Treatment of Obstructive Sleep Apnea on Depressive Symptoms: Systematic Review and Meta-Analysis. PLoS Med 11(11): e32767. doi:10.1371/journal.pmed.1001762
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001762

Souhrn

Zdroje

1. SomersVK, WhiteDP, AminR, AbrahamWT, CostaF, et al. (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118: 1080–1111.

2. Pelletier-FleuryN, MeslierN, GagnadouxF, PersonC, RakotonanaharyD, et al. (2004) Economic arguments for the immediate management of moderate-to-severe obstructive sleep apnoea syndrome. Eur Respir J 23: 53–60.

3. EckertDJ, MalhotraA (2008) Pathophysiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5: 144–153.

4. FleethamJ, AyasN, BradleyD, FergusonK, FitzpatrickM, et al. (2006) Canadian Thoracic Society guidelines: diagnosis and treatment of sleep disordered breathing in adults. Can Respir J 13: 387–392.

5. HarrisM, GlozierN, RatnavadivelR, GrunsteinRR (2009) Obstructive sleep apnea and depression. Sleep Med Rev 13: 437–444.

6. BixlerEO, VgontzasAN, LinHM, CalhounSL, Vela-BuenoA, et al. (2005) Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 90: 4510–4515.

7. GilesTL, LassersonTJ, SmithBJ, WhiteJ, WrightJ, et al. (2006) Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006: CD001106.

8. MarinJM, CarrizoSJ, VicenteE, AgustiAG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046–1053.

9. MarinJM, SorianoJB, CarrizoSJ, BoldovaA, CelliBR (2010) Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 182: 325–331.

10. Martinez-GarciaMA, Soler-CatalunaJJ, Ejarque-MartinezL, SorianoY, Roman-SanchezP, et al. (2009) Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 180: 36–41.

11. HoffsteinV (2007) Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath 11: 1–22.

12. MoherD, LiberatiA, TetzlaffJ, AltmanDG (2009) Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med 3: e123–e130.

13. BeckAT, SteerRA, BallR, RanieriW (1996) Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 67: 588–597.

14. ZigmondAS, SnaithRP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361–370.

15. MontgomerySA, AsbergM (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382–389.

16. NyenhuisDL, YamamotoC, LuchettaT, TerrienA, ParmentierA (1999) Adult and geriatric normative data and validation of the profile of mood states. J Clin Psychol 55: 79–86.

17. YesavageJA, BrinkTL, RoseTL, LumO, HuangV, et al. (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17: 37–49.

18. DerogatisLR, MelisaratosN (1983) The Brief Symptom Inventory: an introductory report. Psychol Med 13: 595–605.

19. RobertsRE, VernonSW (1983) The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am J Psychiatry 140: 41–46.

20. WareJEJr, SherbourneCD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30: 473–483.

21. InterTASC Information Specialists' Sub-Group (2014) The InterTASC Information Specialists' Sub-Group search filter resource. Available: https://sites.google.com/a/york.ac.uk/issg-search-filters-resource/home. Accessed 21 October 2014.

22. Higgins JPT, Green S, editors(2009) Cochrane handbook for systematic reviews of interventions, version 5.0.2. The Cochrane Collaboration.

23. HigginsJPT, AltmanDG, GøtzschePC, JüniP, MoherD, et al. (2011) The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 343: d5928.

24. KjaergaardM, Arfwedson WangCE, WaterlooK, JordeR (2014) A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Asberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population. Scand J Psychol 55: 83–89.

25. ChoiY, MayerTG, WilliamsMJ, GatchelRJ (2014) What is the best screening test for depression in chronic spinal pain patients? Spine J 14: 1175–1182.

26. DennisM, KadriA, CoffeyJ (2012) Depression in older people in the general hospital: a systematic review of screening instruments. Age Ageing 41: 148–154.

27. LewinsohnPM, SeeleyJR, RobertsRE, AllenNB (1997) Center for Epidemiologic Studies Depression Scale (CES-D) as a screening instrument for depression among community-residing older adults. Psychol Aging 12: 277–287.

28. WyrwichKW, YuH (2011) Validation of POMS questionnaire in postmenopausal women. Qual Life Res 20: 1111–1121.

29. Kelly WK, Kelly WK, Halabi S (2010) Oncology clinical trials: successful design, conduct, and analysis. New York: Demos Medical Publishing.

30. AminMM, GoldMS, BroderickJE, GoldAR (2011) The effect of nasal continuous positive airway pressure on the symptoms of Gulf War illness. Sleep Breath 15: 579–587.

31. BardwellWA, NormanD, Ancoli-IsraelS, LoredoJS, LoweryA, et al. (2007) Effects of 2-week nocturnal oxygen supplementation and continuous positive airway pressure treatment on psychological symptoms in patients with obstructive sleep apnea: a randomized placebo-controlled study. Behav Sleep Med 5: 21–38.

32. BarnesM, HoustonD, WorsnopCJ, NeillAM, MykytynIJ, et al. (2002) A randomized controlled trial of continuous positive airway pressure in mild obstructive sleep apnea. Am J Respir Crit Care Med 165: 773–780.

33. BarnesM, McEvoyRD, BanksS, TarquinioN, MurrayCG, et al. (2004) Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 170: 656–664.

34. BlancoJ, ZamarronC, Abeleira PazosMT, LamelaC, Suarez QuintanillaD (2005) Prospective evaluation of an oral appliance in the treatment of obstructive sleep apnea syndrome. Sleep Breath 9: 20–25.

35. CraigSE, KohlerM, NicollD, BrattonDJ, NunnA, et al. (2012) Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea: the MOSAIC randomised controlled trial. Thorax 67: 1090–1096.

36. DiaferiaG, BadkeL, Santos-SilvaR, BommaritoS, TufikS, et al. (2013) Effect of speech therapy as adjunct treatment to continuous positive airway pressure on the quality of life of patients with obstructive sleep apnea. Sleep Med 14: 628–635.

37. EnglemanHM, MartinSE, KingshottRN, MackayTW, DearyIJ, et al. (1998) Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 53: 341–345.

38. EnglemanHM, KingshottRN, WraithPK, MackayTW, DearyIJ, et al. (1999) Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159: 461–467.

39. HaenselA, NormanD, NatarajanL, BardwellWA, Ancoli-IsraelS, et al. (2007) Effect of a 2 week CPAP treatment on mood states in patients with obstructive sleep apnea: a double-blind trial. Sleep Breath 11: 239–244.

40. HenkeKG, GradyJJ, KunaST (2001) Effect of nasal continuous positive airway pressure on neuropsychological function in sleep apnea-hypopnea syndrome. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 163: 911–917.

41. JenkinsonC, DaviesRJ, MullinsR, StradlingJR (1999) Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 353: 2100–2105.

42. LamB, SamK, MokWYW, CheungMT, FongDYT, et al. (2007) Randomised study of three non-surgical treatments in mild to moderate obstructive sleep apnoea. Thorax 62: 354–359.

43. LeeIS, BardwellW, Ancoli-IsraelS, LoredoJS, DimsdaleJE (2012) Effect of three weeks of continuous positive airway pressure treatment on mood in patients with obstructive sleep apnoea: a randomized placebo-controlled study. Sleep Med 13: 161–166.

44. MarshallNS, NeillAM, CampbellAJ, SheppardDS (2005) Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea. Thorax 60: 427–432.

45. MontserratJM, FerrerM, HernandezL, FarreR, VilagutG, et al. (2001) Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: a randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 164: 608–613.

46. NaismithSL, WinterVR, HickieIB, CistulliPA (2005) Effect of oral appliance therapy on neurobehavioral functioning in obstructive sleep apnea: a randomized controlled trial. J Clin Sleep Med 1: 374–380.

47. PetriN, SvanholtP, SolowB, WildschiodtzG, WinkelP (2008) Mandibular advancement appliance for obstructive sleep apnoea: results of a randomised placebo controlled trial using parallel group design. J Sleep Res 17: 221–229.

48. RedlineS, AdamsN, StraussME, RoebuckT, WintersM, et al. (1998) Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 157: 858–865.

49. RyanCM, BayleyM, GreenR, MurrayBJ, BradleyTD (2011) Influence of continuous positive airway pressure on outcomes of rehabilitation in stroke patients with obstructive sleep apnea. Stroke 42: 1062–1067.

50. SandbergO, FranklinKA, BuchtG, ErikssonS, GustafsonY (2001) Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study. Eur Respir J 18: 630–634.

51. SiccoliMM, PepperellJC, KohlerM, CraigSE, DaviesRJ, et al. (2008) Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 31: 1551–1558.

52. SmithLA, VennelleM, GardnerRS, McDonaghTA, DenvirMA, et al. (2007) Auto-titrating continuous positive airway pressure therapy in patients with chronic heart failure and obstructive sleep apnoea: a randomized placebo-controlled trial. Eur Heart J 28: 1221–1227.

53. YuBH, Ancoli-IsraelS, DimsdaleJE (1999) Effect of CPAP treatment on mood states in patients with sleep apnea. J Psychiatr Res 33: 427–432.

54. SteerRA, ClarkDA, BeckAT, RanieriWF (1999) Common and specific dimensions of self-reported anxiety and depression: the BDI-II versus the BDI-IA. Behav Res Ther 37: 183–190.

55. SmarrKL, KeeferAL (2011) Measures of depression and depressive symptoms: Beck Depression Inventory-II (BDI-II), Center for Epidemiologic Studies Depression Scale (CES-D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire-9 (PHQ-9). Arthritis Care Res (Hoboken) 63 (Suppl 11) S454–S466.

56. DouglasN, YoungA, RoebuckT, HoS, MillerBR, et al. (2013) Prevalence of depression in patients referred with snoring and obstructive sleep apnoea. Intern Med J 43: 630–634.

57. RedlineS, AdamsN, StraussME, RoebuckT, WintersM, et al. (1998) Improvement of mild sleep-disordered breathing with CPAP compared with conservative therapy. Am J Respir Crit Care Med 157: 858–865.